345 related articles for article (PubMed ID: 32814993)
41. Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
Sato K; Gosho M; Yamamoto T; Kobayashi Y; Ishii N; Ohashi T; Nakade Y; Ito K; Fukuzawa Y; Yoneda M
Nutrition; 2015; 31(7-8):923-30. PubMed ID: 26059365
[TBL] [Abstract][Full Text] [Related]
42. Liver Disease: Nonalcoholic Fatty Liver Disease.
Cooper J; Baumgartner K; Smith A; St Louis J
FP Essent; 2021 Dec; 511():29-35. PubMed ID: 34855339
[TBL] [Abstract][Full Text] [Related]
43. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.
Castera L; Friedrich-Rust M; Loomba R
Gastroenterology; 2019 Apr; 156(5):1264-1281.e4. PubMed ID: 30660725
[TBL] [Abstract][Full Text] [Related]
44. Treatment of nonalcoholic fatty liver disease in children: TONIC trial design.
Lavine JE; Schwimmer JB; Molleston JP; Scheimann AO; Murray KF; Abrams SH; Rosenthal P; Sanyal AJ; Robuck PR; Brunt EM; Unalp A; Tonascia J;
Contemp Clin Trials; 2010 Jan; 31(1):62-70. PubMed ID: 19761871
[TBL] [Abstract][Full Text] [Related]
45. Intensive Lifestyle Management Improves Steatosis and Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease.
Lefere S; Dupont E; De Guchtenaere A; Van Biervliet S; Vande Velde S; Verhelst X; Devisscher L; Van Vlierberghe H; Geerts A; De Bruyne R
Clin Gastroenterol Hepatol; 2022 Oct; 20(10):2317-2326.e4. PubMed ID: 34871812
[TBL] [Abstract][Full Text] [Related]
46. The search for noninvasive methods to identify liver fibrosis in children with nonalcoholic fatty liver disease.
Mandelia C; Kabbany MN; Conjeevaram Selvakumar PK; Alkhouri N
Biomark Med; 2018 Mar; 12(3):265-273. PubMed ID: 29517271
[TBL] [Abstract][Full Text] [Related]
47. Nonalcoholic Fatty Liver Disease in Children.
Mann JP; Valenti L; Scorletti E; Byrne CD; Nobili V
Semin Liver Dis; 2018 Feb; 38(1):1-13. PubMed ID: 29471561
[TBL] [Abstract][Full Text] [Related]
48. Nonalcoholic fatty liver disease: a challenge for pediatricians.
Nobili V; Alkhouri N; Alisi A; Della Corte C; Fitzpatrick E; Raponi M; Dhawan A
JAMA Pediatr; 2015 Feb; 169(2):170-6. PubMed ID: 25506780
[TBL] [Abstract][Full Text] [Related]
49. The role of bariatric surgery in the management of nonalcoholic steatohepatitis.
Seymour KA; Abdelmalek MF
Curr Opin Gastroenterol; 2021 May; 37(3):208-215. PubMed ID: 33769376
[TBL] [Abstract][Full Text] [Related]
50. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.
Younossi ZM; Loomba R; Anstee QM; Rinella ME; Bugianesi E; Marchesini G; Neuschwander-Tetri BA; Serfaty L; Negro F; Caldwell SH; Ratziu V; Corey KE; Friedman SL; Abdelmalek MF; Harrison SA; Sanyal AJ; Lavine JE; Mathurin P; Charlton MR; Goodman ZD; Chalasani NP; Kowdley KV; George J; Lindor K
Hepatology; 2018 Jul; 68(1):349-360. PubMed ID: 29222917
[TBL] [Abstract][Full Text] [Related]
51. Comparison of diagnostic accuracy of screening tests ALT and ultrasound for pediatric non-alcoholic fatty liver disease.
Draijer LG; Feddouli S; Bohte AE; Vd Baan Slootweg O; Pels Rijcken TH; Benninga MA; Stoker J; Koot BGP
Eur J Pediatr; 2019 Jun; 178(6):863-870. PubMed ID: 30903305
[TBL] [Abstract][Full Text] [Related]
52. Current and future treatment options in non-alcoholic steatohepatitis (NASH).
Lazaridis N; Tsochatzis E
Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):357-369. PubMed ID: 28276821
[TBL] [Abstract][Full Text] [Related]
53. Non-alcoholic Fatty Liver Disease and Diabetes Mellitus.
Khneizer G; Rizvi S; Gawrieh S
Adv Exp Med Biol; 2021; 1307():417-440. PubMed ID: 32424494
[TBL] [Abstract][Full Text] [Related]
54. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
[TBL] [Abstract][Full Text] [Related]
55. The Benefit of Sleeve Gastrectomy in Obese Adolescents on Nonalcoholic Steatohepatitis and Hepatic Fibrosis.
Manco M; Mosca A; De Peppo F; Caccamo R; Cutrera R; Giordano U; De Stefanis C; Alisi A; Baumann U; Silecchia G; Nobili V
J Pediatr; 2017 Jan; 180():31-37.e2. PubMed ID: 27697327
[TBL] [Abstract][Full Text] [Related]
56. Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH study.
Barritt AS; Gitlin N; Klein S; Lok AS; Loomba R; Malahias L; Powell M; Vos MB; Weiss LM; Cusi K; Neuschwander-Tetri BA; Sanyal A
Contemp Clin Trials; 2017 Oct; 61():33-38. PubMed ID: 28735109
[TBL] [Abstract][Full Text] [Related]
57. Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials.
Caussy C; Reeder SB; Sirlin CB; Loomba R
Hepatology; 2018 Aug; 68(2):763-772. PubMed ID: 29356032
[TBL] [Abstract][Full Text] [Related]
58. Therapies in non-alcoholic steatohepatitis (NASH).
Oseini AM; Sanyal AJ
Liver Int; 2017 Jan; 37 Suppl 1(Suppl 1):97-103. PubMed ID: 28052626
[TBL] [Abstract][Full Text] [Related]
59. Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis.
Wildman-Tobriner B; Middleton MM; Moylan CA; Rossi S; Flores O; Chang ZA; Abdelmalek MF; Sirlin CB; Bashir MR
Gastroenterology; 2018 Nov; 155(5):1428-1435.e2. PubMed ID: 30031769
[TBL] [Abstract][Full Text] [Related]
60. Diagnosis and treatment of pediatric nonalcoholic steatohepatitis and the implications for bariatric surgery.
Pardee PE; Lavine JE; Schwimmer JB
Semin Pediatr Surg; 2009 Aug; 18(3):144-51. PubMed ID: 19573756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
